查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1923847

食品级尿石素B市场：依用途、形态、通路、纯度等级及来源划分－2026-2032年全球预测

Food Grade Urolithin B Market by Application, Form, Distribution Channel, Purity Grade, Source - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年食品级尿石素 B 市值为 1.3423 亿美元，预计到 2026 年将成长至 1.4576 亿美元，到 2032 年将达到 2.6854 亿美元，复合年增长率为 10.41%。

关键市场统计数据
基准年 2025 1.3423亿美元
预计年份：2026年 1.4576亿美元
预测年份 2032 2.6854亿美元
复合年增长率 (%) 10.41%

本文对食品级尿石素B进行了清晰、技术性强的介绍，阐述了其生化特性、应用重要性和研发重点。

食品级尿石素B因其独特的生物活性和与多种给药系统的兼容性，已成为多个产品领域备受关注的生物化学成分。从化学角度来看，它是一种肠道菌群代谢产物，因其在细胞维持通路中的潜在作用而备受瞩目，其特性使其能够被添加到外用和口服製剂中。随着消费者对兼具营养、美容和治疗价值的成分的需求日益增长，尿石素B恰好满足了消费者主导的健康趋势和科学支持的功能性宣称。

不断变化的科学、监管和供应链趋势如何重塑食品级尿石素B的机会和发展路径

随着终端用户和监管机构对新型活性成分的证据和来源资讯要求日益提高，生物活性成分领域正在发生变化，而尿石素B正是体现了几个变革性趋势。微生物组研究和代谢体学的科学进展提升了肠道代谢物的重要性，促使配方师重新思考其原料来源和稳定策略。同时，消费者对多功能成分的偏好正在推动跨品类应用。如果研发人员能够证实其宣称，那么能够在一个分子中同时提供护肤功效、系统支持和辅助治疗作用的成分，可望应用于化妆品、膳食补充剂、机能性食品和药品等领域。

2025年美国关税变化对尿石素B价值链筹资策略、供应连续性和合规性的实际影响

2025 年美国关税环境为采购或进口生物活性化合物（例如尿石素 B）的中间体原料、成品製剂和特种包装的相关人员带来了新的考量。关税调整将影响原料选择策略，促使企业更加关注原产国、供应商多元化以及加强区域生产伙伴关係，以降低成本波动。进口商应将 HS 编码分析和关税分类审查纳入采购流程，以确保采购决策反映最终到岸成本和合规义务。

透过详细的細項分析，将尿石素B的技术发展和商业性定位与其用途、製剂、通路和终端用户偏好联繫起来。

细分市场分析凸显了将技术属性与商业策略结合的必要性，从而释放尿石素B在不同应用、配方、分销管道和终端用户路径中的价值。在考虑应用时，开发人员必须评估该成分在化妆品、营养保健品、机能性食品和药品中的适用性。在化妆品领域，护髮和护肤的配方目标各不相同，选择主要基于局部稳定性、皮肤渗透性和配方美观。同时，营养保健品开发人员必须平衡生物利用度和消费者便利性，并密切注意胶囊和粉剂等剂型。机能性食品开发人员在开发棒状和饮料产品时，则着重于感官属性和基质稳定性。而药品应用，例如注射剂和口服製剂，则需要严格的临床证据、注射剂的无菌生产以及口服製剂的严格药典控制。

区域战略考量和监管差异影响美洲、欧洲、中东和非洲以及亚太地区尿石素B的应用和产品开发。

区域趋势将显着影响尿石素B的研发、监管和商业化。相关人员需要根据美洲、欧洲、中东和非洲以及亚太地区的各自优先事项调整策略。在美洲，监管路径和消费者趋势正在推动膳食补充剂和机能性食品的创新，尤其註重成分描述的透明度和洁净标示定位。该地区的製造商通常优先考虑可扩展的供应链和伙伴关係关係，以支持产品的快速改进和消费者导向的证据，从而支持产品宣称。

在尿石素B领域，公司层面的关键优势和竞争优势定义了可靠性、供应安全和技术领先地位。

尿石素B领域的竞争格局取决于科学领先地位、生产能力以及将技术特性转化为可靠产品声明的能力。领先企业往往透过投资检验的生产流程来脱颖而出，这些流程能够确保产品具有稳定的杂质谱和高纯度，适用于食品、化妆品和製药等应用领域。其他企业则专注于围绕专有合成路线、微粉化技术或递送系统建立智慧财产权，以提高生物利用度和稳定性。

为生产者、配方师和商业团队提供切实可行的、优先排序的建议，以加速基于尿石素B产品的负责任开发和市场准入。

产业领导者应采取一系列切实可行的行动，将科学潜力转化为满足监管、商业和消费者期望的永续产品系列：优先建立可靠的成分规格和检验的分析方法，并与商业伙伴共用，以降低准入门门槛并加速产品上市；投资于配方开发，以在代表性基质（用于皮肤和头髮护理的外用系统、用于机能性食品方法、用于营养品的策略B，以确定可行的商业化路径并预测稳定性挑战。

我们采用透明的多学科调查方法，结合文献综述、专家访谈、技术分析和情境规划，为实际决策提供支援。

本研究采用多学科交叉方法，确保研究结果的稳健性和可重复性，同时维持资料来源和分析方法的透明度。调查方法结合了对同行评审文献、监管指导文件和技术白皮书的系统性回顾，以建立尿石素B生化特性和安全性的科学基础。同时，研究人员也对製剂科学家、品质保证专业人员和法规专家进行了初步的定性访谈，以收集有关生产挑战、稳定性控制和功效声明验证的实务经验。

针对尿石素B在多个产品领域的商业化，提出了关于技术可行性、监管要求和策略重点的全面结论

总之，食品级尿石素B在具备适当的证据和生产控制措施的情况下，是一种具有技术前景的成分，在化妆品、营养保健品、机能性食品和药品等领域具有潜在的应用价值。其应用潜力取决于可证实的生物活性、适当的配方策略以及严格的品质管理体系，以确保不同剂型的性能一致性。成功的商业化需要使技术开发与监管要求和区域市场特征相符，同时在关税和物流波动的情况下保持供应链的韧性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 食品级尿石素B市场（依应用领域划分）

  • 化妆品
    • 护髮
    • 护肤
  • 营养补充品
    • 胶囊
    • 粉末
  • 机能性食品
    • 酒吧
    • 饮料
  • 製药
    • 注射
    • 口服

9. 食品级尿石素B依形式市场

  • 胶囊
    • 明胶胶囊
    • 素食胶囊
  • 液体
    • 悬浮液
    • 糖浆
  • 粉末
    • 微粉
    • 标准粉末
  • 药片
    • 包衣片
    • 未包衣片剂

第十章 食品级尿石素B市场及分销管道

  • 在线的
  • 离线

11. 食品级尿石素B市场依纯度等级划分

  • 医药级
  • 食品级

12. 食品级尿石素B市场（依来源划分）

  • 自然的
  • 化学合成

第十三章：食品级尿石素B市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 食品级尿石素B市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 食品级尿石素B市场（依国家划分）

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国食品级尿石素B市场

第十七章 中国食品级尿石素B市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Amazentis SA
  • BOC Sciences
  • Chengdu Biopurify Phytochemicals Ltd.
  • Chromadex, Inc.
  • DSM Nutritional Products AG
  • Hangzhou Excelente Chemicals Co., Ltd.
  • Hunan Sunshine Bio-Tech Co., Ltd.
  • Nutra Green Biotechnology Co., Ltd.
  • PhytoLife Sciences
  • Sabinsa Corporation
  • Selleck Chemicals
  • Shaanxi Pioneer Biotech Co., Ltd.
  • Shandong Longda Bio-Products Co., Ltd.
  • Toronto Research Chemicals Inc.
  • Xi'an Natural Field Bio-Technique Co., Ltd.
Product Code: MRR-7A380DA7C2EE

The Food Grade Urolithin B Market was valued at USD 134.23 million in 2025 and is projected to grow to USD 145.76 million in 2026, with a CAGR of 10.41%, reaching USD 268.54 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 134.23 million
Estimated Year [2026] USD 145.76 million
Forecast Year [2032] USD 268.54 million
CAGR (%) 10.41%

A clear and technically grounded introduction to food grade Urolithin B that defines its biochemical identity, application relevance, and development priorities

Food grade Urolithin B has emerged as a biochemical of interest across multiple product domains due to its distinctive bioactivity profile and compatibility with diverse delivery systems. Chemically, it is a gut microbiome-derived metabolite that has attracted attention for its potential roles in cellular maintenance pathways, and its properties support incorporation into topical and oral formulations. As demand for ingredients that bridge nutritional, cosmetic, and therapeutic value grows, Urolithin B sits at the intersection of consumer-driven wellness trends and scientifically grounded functional claims.

The introduction to this compound must therefore balance enthusiasm with rigor. Manufacturers and formulators need clarity on raw material specifications, grade definitions, and handling parameters that preserve bioactivity through processing and shelf life. Regulatory teams must evaluate allowable claims and required toxicology or stability data based on intended application, whether that is a skin care product, a powdered dietary supplement, or an oral pharmaceutical form. In parallel, product developers must assess formulation compatibility across encapsulation, suspension, and solid dosage approaches to ensure consistent delivery of active material.

Taken together, a strategic approach to Urolithin B prioritizes quality controls, compatibility testing, and early engagement with regulatory pathways. This creates a foundation for responsible innovation and positions stakeholders to translate emerging scientific insights into reproducible, consumer-ready offerings.

How evolving scientific, regulatory, and supply chain forces are reshaping opportunities and development pathways for food grade Urolithin B

The landscape for bioactive ingredients is shifting as end users and regulators demand stronger evidence and provenance for novel actives, and Urolithin B reflects several transformative trends. Scientific progress in microbiome research and metabolomics has elevated the importance of gut-derived metabolites, prompting formulators to rethink sourcing and stability strategies. Concurrently, consumer preference for multitasking ingredients drives cross-category adoption; a single molecule that offers skin benefits, systemic support, or adjunctive therapeutic potential can span cosmetics, supplements, functional foods, and pharmaceuticals if developers can substantiate claims.

Supply chain transparency and traceability have moved from differentiators to prerequisites, and the industry is responding with more rigorous raw material specifications and traceable manufacturing steps. This trend places a premium on suppliers who can demonstrate consistent impurity profiles, validated analytical methods, and scalable manufacturing that preserves the active form. At the same time, formulation science is advancing to support novel delivery formats such as micronized powders for improved bioavailability, suspension systems for liquids, and capsule technologies that protect actives from degradation.

Finally, regulatory scrutiny has increased across jurisdictions, requiring manufacturers to prepare robust safety and stability dossiers before pursuing high-value claims. Taken together, these shifts reward companies that invest early in science-backed claims, compliant manufacturing, and cross-functional collaboration between R&D, regulatory affairs, and commercial teams.

Practical implications of United States tariff changes in 2025 on sourcing strategies, supply continuity, and compliance for Urolithin B value chains

The United States tariff environment in 2025 has introduced additional considerations for stakeholders that source or import intermediary ingredients, finished formulations, and specialized packaging for bioactive compounds such as Urolithin B. Tariff adjustments can affect raw material selection strategies, incentivizing greater scrutiny of origin, supplier diversification, and regional production partnerships to mitigate cost volatility. Importers must now layer harmonized system code analysis and tariff classification reviews into procurement workflows to ensure that procurement decisions reflect total landed costs and compliance obligations.

Beyond direct cost implications, tariffs influence strategic choices such as vertical integration, localized manufacturing, or the pursuit of alternative supply routes. For example, companies may seek domestic contract manufacturing organizations for formulations that require specialized processing like micronization or encapsulation, thereby reducing exposure to cross-border duties and shortening lead times. Conversely, firms with global distribution footprints may coordinate dual-sourcing strategies that leverage tariff differentials without compromising quality.

Regulatory teams also need to account for tariff-driven supply shifts in their risk assessments. Material substitutions or manufacturing moves can change impurity profiles, necessitate additional equivalence studies, or prompt updated stability data submissions. In this environment, proactive scenario planning that models tariff impact on supply chain reliability and product margins becomes an operational imperative for anyone developing or commercializing Urolithin B-containing solutions.

In-depth segmentation insights that connect application, form, channel, and end-user choices to technical development and commercial positioning for Urolithin B

Segmentation analysis reveals where technical attributes and commercial strategies must align to unlock value for Urolithin B across distinct application, form, distribution channel, and end-user pathways. When considering application, developers must map the ingredient's suitability across cosmetics, dietary supplements, functional foods, and pharmaceuticals; within cosmetics, formulation goals diverge between hair care and skin care where topical stability, skin penetration, and formulation aesthetics drive choice, while dietary supplements require attention to dosage forms such as capsules and powders that balance bioavailability and consumer convenience. Functional food developers exploring bars and beverages focus on sensory integration and matrix stability, whereas pharmaceutical deployment across injectables and oral dosage demands rigorous clinical evidence, sterile manufacture for injectables, and tight pharmacopoeial controls for oral forms.

Form decisions further refine product strategy because capsules, liquid, powder, and tablets each present different process, stability, and regulatory demands. Capsule selection between gelatin and veggie materials implicates compatibility with excipients and market preferences for vegetarian-friendly offerings; liquid delivery via suspensions or syrups raises issues of dispersion stability and preservative systems; powder choices between micronized and standard grades affect dissolution and perceived efficacy; and tablet formats, whether coated or uncoated, determine release profiles and manufacturing complexity.

Distribution channels shape market access and messaging. Direct sales enable closer technical dialogue with key accounts, online channels require clear digital claims and robust third-party validation to support purchase decisions, retail demands packaging and shelf presence that communicate benefits at point of sale, and wholesale relationships emphasize consistent supply and margin structures. End-user segmentation into adults, athletes, elderly, and medical patients mandates tailored claim frameworks, dosing considerations, and educational strategies to align product positioning with user needs and safety expectations. Integrating these segmentation layers early enables coherent product design, regulatory preparation, and go-to-market alignment.

Regional strategic considerations and regulatory nuances across Americas, Europe, Middle East & Africa, and Asia-Pacific that shape Urolithin B adoption and product development

Regional dynamics significantly influence how Urolithin B is developed, regulated, and commercialized, with stakeholders needing to adapt strategies to the distinct priorities of the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, regulatory pathways and consumer trends favor innovation in dietary supplements and functional foods, with an emphasis on transparent ingredient narratives and clean-label positioning. Manufacturers here often prioritize scalable supply chains and partnerships that support rapid product iteration and consumer-facing evidence to substantiate claims.

Europe, Middle East & Africa presents a mosaic of regulatory frameworks and consumer expectations that place a strong emphasis on clinical substantiation and rigorous labeling. In many EMEA jurisdictions, claims are tightly regulated and technical dossiers must be prepared to address both safety and substantiation requirements; consequently, companies commonly invest in clinical studies and detailed safety assessments prior to market entry. Producers may also face stricter environmental and packaging regulations, influencing material choices and supply chain design.

Asia-Pacific reflects diverse market maturities where demand for innovative functional ingredients coexists with high sensitivity to price and local cultural preferences. In several APAC markets, there is rapid uptake of novel nutraceuticals and cosmetics when supported by credible efficacy data, but success often requires adapting formulations to local dosage preferences, flavor profiles, and regulatory submission processes. Across all regions, alignment between regulatory planning, formulation development, and commercial strategy is essential to navigate regional nuances and accelerate adoption.

Key company-level strengths and competitive differentiators that determine trust, supply reliability, and technical leadership in the Urolithin B sector

Competitive dynamics in the Urolithin B space are shaped by a combination of scientific leadership, manufacturing capability, and the ability to translate technical attributes into trusted product claims. Key players tend to differentiate through investments in validated manufacturing processes that ensure consistent impurity profiles and high-purity grades suited for food, cosmetic, and pharmaceutical use. Others focus on building intellectual property around proprietary synthesis routes, micronization technologies, or delivery systems that improve bioavailability and stability.

Some companies emphasize vertical integration, offering end-to-end services from precursor sourcing to finished dosage forms, which reduces risks associated with third-party variability and supports rapid technical troubleshooting. Strategic partnerships between ingredient producers and contract formulators or clinical research organizations are also common, enabling faster validation of efficacy claims and smoother regulatory submissions. In parallel, certain suppliers specialize in analytical method development and stability testing services tailored to Urolithin B, supporting customers who require strengthened quality control and batch-release workflows.

Finally, firms that invest in transparent documentation, third-party testing, and traceability tools position themselves favorably with both regulators and commercial customers. This alignment of technical rigor, supply reliability, and evidentiary support defines competitive differentiation and influences buyer trust across cosmetics, supplements, functional foods, and pharmaceutical segments.

Actionable and prioritized recommendations for manufacturers, formulators, and commercial teams to accelerate responsible development and market entry of Urolithin B applications

Industry leaders should pursue a set of pragmatic actions to convert scientific promise into sustainable product portfolios that meet regulatory, commercial, and consumer expectations. Prioritize establishing robust raw material specifications and validated analytical methods that can be shared with commercial partners to reduce onboarding friction and expedite product launches. Invest in formulation development that evaluates Urolithin B across representative matrices-topical systems for skin and hair care, encapsulation strategies for supplements, beverage and bar prototypes for functional foods, and sterile and oral processes for pharmaceutical considerations-to identify feasible commercialization paths and anticipate stability challenges.

Simultaneously, embed regulatory intelligence into project planning by engaging with regulatory specialists early to map evidence requirements by intended use and jurisdiction. Where appropriate, design clean, targeted clinical or human-use studies that address both safety and function to underpin higher-value claims. Strengthen supply chain resilience through supplier audits, dual-sourcing strategies for critical precursors, and consideration of regional manufacturing partnerships that mitigate tariff and logistics exposure.

Lastly, cultivate transparent communication practices that include third-party verification and traceability data to build end-user and retail confidence. Combining technical investment with proactive regulatory engagement and supply chain planning creates the operational resilience required to scale responsibly and capture cross-category opportunities.

A transparent and multidisciplinary research methodology combining literature review, expert interviews, technical analysis, and scenario planning to support practical decision making

This research integrates multidisciplinary methods to ensure robust, reproducible insights while maintaining transparency around data sources and analytical approaches. The methodology combined a systematic review of peer-reviewed literature, regulatory guidance documents, and technical white papers to establish a scientific baseline for Urolithin B's biochemical properties and safety considerations. In parallel, primary qualitative interviews with formulation scientists, quality assurance professionals, and regulatory specialists provided practical perspectives on manufacturing challenges, stability management, and claim substantiation.

Analytical evaluation included assessment of publicly available pharmacopoeial and standards documents relevant to ingredient specification, alongside technical reports describing micronization, encapsulation, and liquid suspension techniques that influence deliverable forms. Supply chain implications were explored through scenario analysis that considered supplier diversification, tariff impacts, and regional manufacturing footprints. Throughout, evidence was cross-validated to ensure consistency and to identify areas where further empirical work would most benefit product developers, such as head-to-head formulation trials or region-specific regulatory studies.

Transparency was maintained by documenting inclusion criteria for literature and interviewee selection, and by distinguishing between peer-reviewed science and industry practice insights. This blended approach produces actionable conclusions while highlighting knowledge gaps where targeted research or validation studies would strengthen confidence for commercial deployment.

A comprehensive conclusion summarizing the technical promise, regulatory imperatives, and strategic priorities for commercializing Urolithin B across multiple product domains

In conclusion, food grade Urolithin B represents a technically promising ingredient with applications that span cosmetics, dietary supplements, functional foods, and pharmaceutical contexts when supported by appropriate evidence and manufacturing controls. Its potential rests on demonstrable bioactivity, appropriate formulation strategies, and rigorous quality systems that ensure consistent performance across delivery formats. Successful commercialization will depend on aligning technical development with regulatory expectations and regional market nuances, while maintaining supply chain resilience in the face of tariff and logistics variability.

Stakeholders that prioritize validated analytical methods, invest in formulation and stability testing across relevant matrices, and plan for jurisdiction-specific regulatory requirements will be best positioned to translate scientific promise into trustworthy products. Cross-functional collaboration among R&D, regulatory affairs, quality, and commercial teams is essential to navigate the technical and evidentiary hurdles that accompany high-value claims. With measured investment in evidence generation and supply chain integrity, Urolithin B can be responsibly developed into compelling products that meet both consumer demand and regulatory standards.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Food Grade Urolithin B Market, by Application

  • 8.1. Cosmetics
    • 8.1.1. Hair Care
    • 8.1.2. Skin Care
  • 8.2. Dietary Supplements
    • 8.2.1. Capsules
    • 8.2.2. Powder
  • 8.3. Functional Foods
    • 8.3.1. Bars
    • 8.3.2. Beverages
  • 8.4. Pharmaceuticals
    • 8.4.1. Injectables
    • 8.4.2. Oral Dosage

9. Food Grade Urolithin B Market, by Form

  • 9.1. Capsules
    • 9.1.1. Gelatin Capsules
    • 9.1.2. Veggie Capsules
  • 9.2. Liquid
    • 9.2.1. Suspensions
    • 9.2.2. Syrups
  • 9.3. Powder
    • 9.3.1. Micronized Powder
    • 9.3.2. Standard Powder
  • 9.4. Tablets
    • 9.4.1. Coated Tablets
    • 9.4.2. Uncoated Tablets

10. Food Grade Urolithin B Market, by Distribution Channel

  • 10.1. Online
  • 10.2. Offline

11. Food Grade Urolithin B Market, by Purity Grade

  • 11.1. Pharmaceutical Grade
  • 11.2. Food Grade

12. Food Grade Urolithin B Market, by Source

  • 12.1. Natural
  • 12.2. Chemical

13. Food Grade Urolithin B Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Food Grade Urolithin B Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Food Grade Urolithin B Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Food Grade Urolithin B Market

17. China Food Grade Urolithin B Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Amazentis SA
  • 18.6. BOC Sciences
  • 18.7. Chengdu Biopurify Phytochemicals Ltd.
  • 18.8. Chromadex, Inc.
  • 18.9. DSM Nutritional Products AG
  • 18.10. Hangzhou Excelente Chemicals Co., Ltd.
  • 18.11. Hunan Sunshine Bio-Tech Co., Ltd.
  • 18.12. Nutra Green Biotechnology Co., Ltd.
  • 18.13. PhytoLife Sciences
  • 18.14. Sabinsa Corporation
  • 18.15. Selleck Chemicals
  • 18.16. Shaanxi Pioneer Biotech Co., Ltd.
  • 18.17. Shandong Longda Bio-Products Co., Ltd.
  • 18.18. Toronto Research Chemicals Inc.
  • 18.19. Xi'an Natural Field Bio-Technique Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FOOD GRADE UROLITHIN B MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FOOD GRADE UROLITHIN B MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY HAIR CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY HAIR CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY SKIN CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY BARS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY BARS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY BARS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY INJECTABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY INJECTABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY ORAL DOSAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY ORAL DOSAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY ORAL DOSAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY GELATIN CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY GELATIN CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY GELATIN CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY VEGGIE CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY VEGGIE CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY VEGGIE CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY SUSPENSIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY SUSPENSIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY SYRUPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY SYRUPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY SYRUPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY MICRONIZED POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY MICRONIZED POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY MICRONIZED POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY STANDARD POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY STANDARD POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY STANDARD POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY COATED TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY COATED TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY COATED TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY UNCOATED TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY UNCOATED TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY UNCOATED TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY FOOD GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY FOOD GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY FOOD GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY NATURAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY NATURAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY NATURAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY CHEMICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY CHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY CHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS FOOD GRADE UROLITHIN B MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE FOOD GRADE UROLITHIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST FOOD GRADE UROLITHIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC FOOD GRADE UROLITHIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN FOOD GRADE UROLITHIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 233. GCC FOOD GRADE UROLITHIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. GCC FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. GCC FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 236. GCC FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 237. GCC FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 238. GCC FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 239. GCC FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 240. GCC FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 241. GCC FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 242. GCC FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 243. GCC FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 244. GCC FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. GCC FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 246. GCC FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION FOOD GRADE UROLITHIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS FOOD GRADE UROLITHIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 275. G7 FOOD GRADE UROLITHIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. G7 FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. G7 FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 278. G7 FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 279. G7 FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 280. G7 FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 281. G7 FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 282. G7 FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 283. G7 FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 284. G7 FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 285. G7 FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 286. G7 FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. G7 FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 288. G7 FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 289. NATO FOOD GRADE UROLITHIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 290. NATO FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. NATO FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 292. NATO FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 293. NATO FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 294. NATO FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 295. NATO FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 296. NATO FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 297. NATO FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 298. NATO FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 299. NATO FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 300. NATO FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. NATO FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 302. NATO FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 303. GLOBAL FOOD GRADE UROLITHIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 318. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 319. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, BY TABLETS, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 330. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 331. CHINA FOOD GRADE UROLITHIN B MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)